Hepatitis B, C, and D Virus Infection among Population Aged 10–64 Years in Mongolia: Baseline Survey Data of a Nationwide Cancer Cohort Study

Author:

Dambadarjaa DavaalkhamORCID,Radnaa Otgonbayar,Khuyag Ser-Od,Shagdarsuren Oyu-Erdene,Enkhbayar Uranbaigali,Mukhtar Yerkyebulan,Tsogzolbaatar Enkh-Oyun,Nyam GunchmaaORCID,Shaarii Shatar,Singh PramilORCID,Takahashi Masaharu,Namdag Bira,Okamoto HiroakiORCID

Abstract

Hepatitis B, C, and D virus infections are a major public health problem, and Mongolia has one of the highest prevalences of dual and triple infections in the world. We aimed to determine the seroprevalence of hepatitis infection and dual or triple hepatitis infections among 10–64-year-olds. A questionnaire was used to identify risk factors for hepatitis infection, and seromarkers were measured by the fully automated immunologic analyzer HISCL-5000. Among a total of 10,040 participants, 8.1% of the population aged 10–64 was infected with HBV, 9.4% with HCV, and 0.4% with HBV and HCV, and the prevalence of the disease varied by age, sex, and the area of residence. Young people were particularly unaware of their hepatitis infection status. A small proportion of children aged 10 to 19 years and the majority of adults younger than 30 years were unaware of their HBV and HCV infection. Men were also more likely to be unaware of their HBV and HCV infection status than women. The results suggested that the prevalence of infection in the general population is high and that most people are unaware that they are infected or have become chronic carriers. Identifying mono-, co-, or triple-infection status is critical to prevent the rapid progression of liver disease among the Mongolian population.

Funder

“SYSMEX” corporation of Japan

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference31 articles.

1. Viral Hepatitis and Liver Cancer;Philos. Trans. R. Soc. Lond. B Biol. Sci.,2017

2. World Health Organization (2022, May 31). Hepatitis B. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.

3. (2022, May 31). World Health Organization. Available online: https://apps.who.int/iris/rest/bitstreams/1348210/retrieve.

4. World Health Organization (2022, May 31). Global Health Sector Strategy on Viral Hepatitis 2016–2021. Available online: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf.

5. Global Cancer Statistics, 2012;CA A Cancer J. Clin.,2015

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3